FDA and FTC Encourage Biosimilar Competition

March 9, 2020

FDA and FTC Encourage Biosimilar Competition

The FDA and FTC signed a joint agreement supporting biosimilar market competition and describing steps both agencies will take to deter anticompetitive behavior. “Competition is key for helping American patients have access to affordable medicines,”said FDA Commissioner Stephen M. Hahn, M.D. Yourway is committed to moving and storing samples affordably on a global scale to increase patient access.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Schedule a Meeting

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat

Hello! How can I help you?